A literature review revealed that several factors, including age, tumor size, tumor-node-metastasis (TNM) stage, epidermal growth factor receptor (EGFR) status, surgical approach, radiation therapy, and chemotherapy, can influence the prognosis of SRCC patients (11–18). The gene discussed is EGFR; the disease is neoplasm.